concussion

Intranasal delivery of the NMDA receptor antagonist MK-801 attenuates ultra-acute excitotoxic neurochemical responses after concussion in rats: comparative pharmacological evaluation against ketamine

Study Overview The research investigates the effects of MK-801, an NMDA receptor antagonist, administered intranasally on neurochemical responses following concussion

Intranasal delivery of the NMDA receptor antagonist MK-801 attenuates ultra-acute excitotoxic neurochemical responses after concussion in rats: comparative pharmacological evaluation against ketamine Read Post »

Scroll to Top